CVE-2012-6092

Description

Multiple cross-site scripting (XSS) vulnerabilities in the web demos in Apache ActiveMQ before 5.8.0 allow remote attackers to inject arbitrary web script or HTML via (1) the refresh parameter to PortfolioPublishServlet.java (aka demo/portfolioPublish or Market Data Publisher), or vectors involving (2) debug logs or (3) subscribe messages in webapp/websocket/chat.js. NOTE: AMQ-4124 is covered by CVE-2012-6551.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 1.94% Top 20%
Vendor Advisory redhat.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://rhn.redhat.com/errata/RHSA-2013-1029.html vendor advisory
http://www.securityfocus.com/bid/59400 vdb entry
https://issues.apache.org/jira/browse/AMQ-4115
https://fisheye6.atlassian.com/changelog/activemq?cs=1399577
http://activemq.apache.org/activemq-580-release.html
https://issues.apache.org/jira/secure/ReleaseNote.jspa?projectId=12311210&version=12323282

Frequently Asked Questions

What is the severity of CVE-2012-6092?
CVE-2012-6092 has been scored as a medium severity vulnerability.
How to fix CVE-2012-6092?
To fix CVE-2012-6092, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2012-6092 being actively exploited in the wild?
It is possible that CVE-2012-6092 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~2% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.